CJC-1295 research guide

CJC-1295 in Graft — GHRH Analog Research Guide

CJC-1295 research guide for Graft. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

CJC-1295 in Graft — Research & Sourcing Guide

Most researchers looking for CJC-1295 in Graft immediately realize that local retail options are nearly impossible to find. The upside of this online-only market is that serious vendors compete aggressively on their analytical documentation, giving researchers better verification tools than local retail ever could. What consistently distinguishes top CJC-1295 vendors is comprehensive lot-matched testing data: HPLC for purity, mass spec for peptide identity confirmation, and endotoxin testing for contamination assurance. Use this guide to assess sourcing options methodically — the quality evaluation approach outlined here are universal across all research contexts.

How CJC-1295 Works — Mechanisms & Research

CJC-1295 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Graft studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.

How to Evaluate CJC-1295 Vendors

Quality CJC-1295 sourcing begins with a useful first test: does this vendor make batch-matched COAs available before purchase? Vendors who do are demonstrating research-grade standards. When reviewing a CJC-1295 COA, verify: the batch number matches your product, HPLC purity is ≥98%, mass spec identifies the correct molecular weight, and endotoxin levels are below the threshold for research use. Community reputation in research forums is a useful additional signal to COA verification — vendors with sustained positive community feedback have built their reputation on real product performance. Price is an poor proxy for CJC-1295 quality — research-grade synthesis and testing has real costs that do not compress without quality compromise, so significantly below-market pricing signals compromises.

Order CJC-1295 — ships to Graft
COA-verified · International tracking · Research grade
Order Now →

CJC-1295 Research Safety Guide

As a research compound, CJC-1295 has not completed the clinical trial process required for pharmaceutical approval — its safety profile is based on preclinical research and small-scale human observations. Storage requirements for CJC-1295: lyophilised powder at freezer temperature, reconstituted solution stored refrigerated at 2-8°C and consumed within 4 weeks; reconstitute only with sterile bacteriostatic water. Bacterial endotoxin contamination is the greatest safety hazard specific to research peptides — verify endotoxin testing is included in the batch-specific COA before any injectable research application. For any individual considering CJC-1295 outside a formal research context: consult a qualified physician — this compound is not a licensed human medication and its safety characterisation does not match that of regulated drugs.

Frequently Asked Questions

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →